BioSpace News Archive

Titan Pharmaceuticals, Inc. will announce its first quarter 2019 financial results after market close on Wednesday, May 15, 2019.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from a Phase 2 trial (NCT02982972) evaluating the safety, tolerability and immunogenicity of V114, the company’s investigational 15-valent pneumococcal conjugate vaccine, as compared to the currently available 13-valent pneumococcal conjugate vaccine (PCV13) in healthy infants 6-12 weeks of age.

ALung Technologies, Inc. announced the achievement of a major milestone in its U.S. based VENT-AVOID clinical trial and reports continued progress in its clinical trial programs.

Dow earned the 37th place on the 2019 Top 50 Companies for Diversity list from DiversityInc, which was announced yesterday at DiversityInc’s annual celebratory event in New York City.

CURE Media Group — which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates, research and education — welcomes Triage Cancer to its Strategic Alliance Partnership program.

In recognition of Women’s Health Month in May, Fidelis Care announced its Being Healthy is BeYOUtiful initiative, focused on the importance of empowering women to make their health a priority.

ClearDATA executives serving on HSCC task forces to address security in medical devices and cybersecurity best practices

Traceable protein welcomed as new tool to help validate integrity of supply chain

SBIR-funded companies will showcase biotechnology breakthroughs at BIO 2019 International Convention

Medical travelers from the United States and around the world now have the option to access a complete annual physical together with comprehensive anti-aging and wellness services in one location and over just two to three days at Bumrungrad International Hospital and its seamlessly integrated subsidiary located on the same campus downtown, VitalLife Scientific Wellness Center.